Filter posts

2011, The Year of Positive Thinking? BIO/IPREO Study Reveals High Hopes for the Industry

BIO CEO’s closing plenary session featured plenty of crystal ball gazing and candid quips about …

Release of BIO/Biomedtracker Drug Approval Rates Study

BIO and BioMedTracker are pleased to present the findings of their joint clinical trial success …

Effective Tax Rates for Biotech

The New York Times published a misleading article and companion blog post on corporate tax …

2010 Biotech Stock Performance

How did biotech stocks perform in 2010? It was a good year for the two …

IPO UPDATE – JANUARY 4th, 2011

In 2010 we saw the return of the Biotech IPO. In the US, 17 biotech …

How Profitable is the Biotech Drug Development Sector?

Q: How many public biotechnology companies focused on pursuing drug development are profitable? A: Less …

Update - Analysis of Therapeutic Discovery Project Awards

Here are the results from our recent analysis of the Therapeutic Discovery Project. (For additional …

Clinical Trial Success Rates - Recent Study from Tufts

Joseph DiMasi and his team at Tufts University published a paper earlier this year in …

IPO Update - November 11th, 2010

Today’s IPO from Complete Genomics (GNOM) brings the US biotech IPO list to 17 since …

Therapeutic Discovery Project Awards Provide Much Needed R&D Support

This morning, U.S. Treasury Secretary Timothy Geithner and HHS Secretary Kathleen Sebelius announced the awardees …